blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1863525

EP1863525 - POLYPEPTIDES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.07.2010
Database last updated on 28.05.2024
Most recent event   Tooltip02.07.2010Application deemed to be withdrawnpublished on 04.08.2010  [2010/31]
Applicant(s)For all designated states
Absynth Biologics Ltd
40 Leavygreave Road
Sheffield S3 7RD / GB
[2008/26]
Former [2007/50]For all designated states
Absynth Biologics Ltd
40 Leavygreave Road
Sheffield S2 7RD / GB
Inventor(s)01 / FOSTER, Simon, J.
Cedar Croft Higger Lane
Hathersage S32 1AW / GB
02 / GARCIA-LARA, Jorge
9 Midvale Avenue
Sheffield S6 3HJ / GB
 [2007/51]
Former [2007/50]01 / FOSTER, Simon, J.
Cedar Croft Higger Lane
Hathersage S32 1AW / GB
02 / GARCIA-LARCA, Jorge
9 Midvale Avenue
Sheffield S6 3HJ / GB
Representative(s)O'Neill, Michelle, et al
Harrison IP Limited
3 Ebor House
London Ebor Business Park
Millfield Lane
Nether Poppleton York YO26 6QY / GB
[N/P]
Former [2009/46]O'Neill, Michelle, et al
Harrison IP Limited Marlborough House Westminster Place York Business Park
Nether Poppleton, York YO26 6RW / GB
Former [2008/26]O'Neill, Michelle, et al
Gilholm Harrison Limited 1st Floor, Marlborough House Westminster Place, York Business Park Nether Poppleton
York YO26 6RW / GB
Former [2007/50]O'Neill, Michelle
Gilholm Harrison Limited 1st Floor, Marlborough House Westminster Place, York Business Park Nether Poppleton
York YO26 6RW / GB
Application number, filing date06710041.208.03.2006
[2007/50]
WO2006GB00826
Priority number, dateGB2005000594923.03.2005         Original published format: GB 0505949
[2007/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006100430
Date:28.09.2006
Language:EN
[2006/39]
Type: A2 Application without search report 
No.:EP1863525
Date:12.12.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 28.09.2006 takes the place of the publication of the European patent application.
[2007/50]
Search report(s)International search report - published on:EP21.12.2006
ClassificationIPC:A61K39/07, A61K39/085, A61K39/395, C07K7/06, C07K14/31
[2007/50]
CPC:
C07K16/1271 (EP,US); A61K39/07 (EP,US); A61K39/085 (EP,US);
A61K39/40 (US); A61P1/04 (EP); A61P11/00 (EP);
A61P17/00 (EP); A61P21/00 (EP); A61P27/16 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/06 (EP);
A61P37/04 (EP); A61P7/00 (EP); C07K14/31 (EP,US);
C07K14/32 (EP,US); C07K16/1278 (EP,US); A61K38/00 (EP,US);
Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/50]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:POLYPEPTIDE[2007/50]
English:POLYPEPTIDES[2007/50]
French:POLYPEPTIDES[2007/50]
Entry into regional phase15.10.2007National basic fee paid 
15.10.2007Designation fee(s) paid 
15.10.2007Examination fee paid 
Examination procedure15.10.2007Amendment by applicant (claims and/or description)
15.10.2007Examination requested  [2007/50]
01.04.2008Despatch of a communication from the examining division (Time limit: M06)
19.01.2009Reply to a communication from the examining division
28.07.2009Despatch of a communication from the examining division (Time limit: M06)
09.02.2010Application deemed to be withdrawn, date of legal effect  [2010/31]
15.03.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/31]
Divisional application(s)EP10075018.1  / EP2213297
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
19.01.2009Request for further processing filed
19.01.2009Full payment received (date of receipt of payment)
Fees paidRenewal fee
05.02.2008Renewal fee patent year 03
12.03.2009Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.201005   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US6627747  (FRITZ CHRISTIAN [US], et al) [X] 1-32 * abstract * * column 1, line 26 - line 36 * * column 2, line 30 - line 66 * * table 2 * * column 4, line 50 - line 64 * * column 5, line 46 - line 56 * * column 6, line 59 - line 62 * * column 7, line 54 - line 60 * * column 8, line 15 - line 25 * * column 10, line 44 - line 67 * * column 16, line 8 - column 18, line 62 *;
 [X]WO0014200  (MILLENNIUM PHARM INC [US]) [X] 1-32 * abstract * * table 1 * * page 3, line 25 - page 4, line 12 * * table 2 * * page 9, line 12 - page 11, line 20 * * page 15, line 24 - page 16, line 32 * * page 18, line 30 - page 19, line 3 * * page 20, line 20 - page 22, line 20 * * page 32, line 32 - page 38, line 23 * * page 49, line 15 - page 62, line 8 * * claims 20-29 *;
 [A]US2004235085  (FRITZ CHRISTIAN [US], et al) [A] 1-32 * the whole document *;
 [A]US2003180821  (TOMICH CHE-SHEN C [US], et al) [A] 1-32 * the whole document *;
 WO0170955  [ ] (ELITRA PHARMACEUTICALS INC [US], et al);
 WO02077183  [ ] (ELITRA PHARMACEUTICALS INC [US], et al);
 WO0170955  [ ] (ELITRA PHARMACEUTICALS INC [US], et al) [ ] * example 3 * * sequence 5305 *;
 WO02077183  [ ] (ELITRA PHARMACEUTICALS INC [US], et al) [ ] * claim 25 * * sequence 44479 *;
 [X]WO0013694  (SMITHKLINE BEECHAM CORP [US]) [X] 1-32 * abstract * * page 19, line 12 - page 20, line 33 * * page 27, line 32 - page 30, line 5 *;
 WO02077183  [ ] (ELITRA PHARMACEUTICALS INC [US], et al) [ ] * claim 25 * * sequence 44158 *
 [A]  - HASELBECK ET AL., GSP, (20020214), Database accession no. AAU33809, URL: EBI, XP002385001 [A] 1-32 * column A *
 [A]  - WANG ET AL., Geneseq, (20031003), Database accession no. ACA20104, URL: EBI, XP002385002 [A] 1-32 * column A *
 [X]  - HASELBECK ET AL., EPO PROTEINS, (20030214), Database accession no. AAU33809, URL: EBI, XP002400411 [X] 1-32 * column A *
 [X]  - WANG ET AL., EPO, (20020619), Database accession no. ABU16555, URL: EBI, XP002400412 [X] 1-32 * column A *
 [X]  - WANG ET AL., EPO PROTEINS, (20030619), Database accession no. ABU16234, URL: EBI, XP002400413 [X] 1-32 * column A *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.